macro

Supreme Court upholds forensic audit in Fortis-Daiichi case

India's Supreme Court rejected appeals by DCB Bank and UBS against a forensic audit tied to Fortis Healthcare, limiting its scope to specific transactions.

on the website stories appear 15 minutes after publication, in the api at once. connect the api →

what happened

India's Supreme Court on Friday rejected appeals from DCB Bank and UBS Management Services India against a Delhi High Court directive for a forensic audit of dealings linked to hospital operator Fortis Healthcare (FHL), according to TradingView. The directive stems from an arbitration dispute involving Daiichi Sankyo.

The bench, headed by Chief Justice Surya Kant, said the audit ordered on August 31 covers only transactions between FHL, its parent Fortis Healthcare (FHHPL) and former owners Malvinder and Shivinder Singh. The court described the banks' role as secondary and supportive, not an open-ended probe of their business.

The banks argued that Daiichi did not seek an audit of them, that they had neither enforced pledges nor sold shares, and that they were not parties to the 2016 arbitral award. Earlier, on September 29, the court had dismissed similar appeals from YES Bank and Axis Bank.

why it matters

For markets, the ruling is mainly a legal matter: it narrows the scope of the review and clears up uncertainty about the banks' role in the case. The text does not point to major consequences for the banks' shares or Fortis, but the case keeps investors' attention on share pledges within the Fortis group.

tags

instruments

DCB BankUBSFortis HealthcareYES BankAxis Bank

sources

  1. Apex Court Upholds Forensic Audit in Daiichi-Fortis Case — ru.tradingview.com, 17 October 2026 at 04:16 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

on the website stories appear 15 minutes after publication, in the api at once.

get stories in real time ↗